Ex­clu­sive: Covid and epi­dem­ic threat biotech Aeri­um Ther­a­peu­tics clos­es af­ter emer­gence of vari­ants

Aeri­um Ther­a­peu­tics has ceased op­er­a­tions, end­ing its mis­sion to bring to mar­ket new an­ti­bod­ies to pro­tect im­muno­com­pro­mised peo­ple from Covid-19, de­vel­op high­ly sought-af­ter long Covid …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER